Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Completed

Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers

NCT00788684

Conditions
CD20-Positive Lymphoid Malignancies, Chronic Lymphoid Leukemia, Hematologic Diseases, +16 more
Locations
  • University of Arizona Cancer Center - North Campus /ID# 16721 Tucson, Arizona, United States
  • Stanford University School of Med /ID# 9782 Stanford, California, United States
  • Cleveland Clinic Main Campus /ID# 9784 Cleveland, Ohio, United States
  • Univ of Wisconsin Hosp/Clinics /ID# 21701 Madison, Wisconsin, United States
View Trial Details
Completed

MB-CART20.1 Lymphoma

NCT03664635

Conditions
B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
Locations
  • University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany
  • Universitätsklikum Leipzig, AöR Leipzig, Germany
View Trial Details
Completed

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

NCT01755975

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Saint Francis/Mount Sinai Regional Cancer Center Hartford, Connecticut, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
View Trial Details
Completed

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

NCT03955783

Conditions
Acute Myeloid Leukemia, Diffuse Large B-cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Roswell Park Cancer Center Buffalo, New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers

NCT01597219

Conditions
Acquired Bone Marrow Failure Syndromes, Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, +33 more
Locations
  • Birmingham Heartlands Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
  • Beatson Hospital Glasgow, United Kingdom
View Trial Details
Completed

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

NCT00596154

Conditions
CNS Brain Cancer, CNS Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma

NCT02961881

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
View all 17 locations
View Trial Details

Related conditions